Title: Covid 19- Sustainable healthcare& laboratory infrastructures - Consortium Climate & Health & Prevention

Biography:

Dr. Ivana Haluskova Balter is a Medical and scientific consultancy and advocacy for partnership PPP – ONE Health & ONE Planet, France

Abstract

Bacteria, viruses, parasites and fungi that are resistant to drug cause 700,000 death each year. By 2050 superbugs inured to treatments could cause up to 10 million deaths annually and costs the global economy US$100 trillion. AMR (antimicrobial) resistance is regarded given Covid -19 lesson again nowadays as a major threat to global public health. Pandemics brought to our attention use of antibiotics given ARDS, hospitalization, hospital acquired pneumonia and ventilator associated pneumonia where particularly in gram negative resistance to last line treatment observed thus framing health as a “global security issue”. as recent example previously Ebola, MERS,SRAS.Cancer and diabetic (association with tuberculosis is known given immune lowered capacities in diabetic patients)  given their “at risk “ groups and hospital frontline workers are most exposed to virus with high transmissibility and several approaches – plasma, treatment and vaccines under evaluation and review of regulatory bodies with several pending question given time from signal to action.